During metastasis, invasive cells must transverse tissue barriers comprised by a variety of extracellular matrices (ECM). This process depends on the ability of tumor cells to degrade the surrounding matrices and then migrate through the matrix defects.1) Matrix metalloproteinase (MMP)-2 (type IV collagenase; gelatinase A) has been suggested to play a role in tumor metastasis.2) The activity of MMP-2 is regulated at three steps: gene expression by several transcription factors, proenzyme processing by tissue inhibitors of metalloproteinase-2 and membrane-type metalloproteinases, and inhibition of enzymatic activity by naturally occurring tissue inhibitors of metalloproteinases.3) Recently, the mechanisms of human MMP-2 gene expression in cancer cells have become clear. Qin et al. 4) demonstrated that several transcription factors, including Sp1, Sp3 and AP-2, participate in the control of constitutive MMP-2 gene expression. The same group also demonstrated that Brg-1 plays a role in the regulation of constitutive expression of the MMP-2 gene by recruitment of Sp1, AP-2 and Pol II to the MMP-2 promoter.5) Furthermore, p53 has been also shown to transcriptionally activate the expression of the human MMP-2 gene.6) Interestingly, it was reported that ATF3 interferes with human MMP-2 expression by antagonizing p53-dependent activation of the MMP-2 gene promoter.
7)On the other hand, four regulatory cis-elements for the gene expression of rat MMP-2 have been identified. Analyses of rat MMP-2 gene transcription have demonstrated that specific interaction of the nuclear factor YB-1, a member of the Y-box transcription factor family, with a 40-bp enhancer element, denoted as RE-1, located at nucleotide positions Ϫ1322 to Ϫ1282 relative to the translational start site is necessary for potent expression of the rat MMP-2 gene.8,9) The same authors have also shown that combinatorial interaction of AP-2 and p53 with YB-1 in RE-1 yields more increased MMP-2 expression.10) Another regulator of rat MMP-2 transcription, nm23-b, that acts by competitive interference with the transactivator YB-1, leading to suppression of MMP-2 transcription, has also been identified in RE-1.11) Moreover, under hypoxic conditions, MMP-2 transcription has been reported to be regulated in an AP-1-binding site located at positions Ϫ1394 to Ϫ1385 through JunB/Fra1 and JunB/FosB heterodimers.12) An additional silencer element in which PU.1 transcription factor binds was isolated in a further upstream region (positions Ϫ1854 to Ϫ1849) of the rat MMP-2 gene.13) In addition to the PU.1 binding element, AP-1 binding element and RE-1, a fourth region at positions Ϫ1021 to Ϫ972, designated RE-2, was identified as an Ets-1-binding site in which rat MMP-2 transcription was increased through Ets-1 transcription factor.
14)We previously showed that extracellular matrix tenascin-X-deficient (TNX-/-) mice exhibit promotion of tumor invasion and metastasis due to increased levels of MMP-2 and MMP-9 activities.15) It has also been revealed that the induction of MMP...